Cargando…
Progranulin Levels in Plasma and Cerebrospinal Fluid in Granulin Mutation Carriers
BACKGROUND: Pathogenic mutations in the granulin gene (GRN) are causative in 5-10% of patients with frontotemporal dementia (FTD), mostly leading to reduced progranulin protein (PGRN) levels. Upcoming therapeutic trials focus on enhancing PGRN levels. METHODS: Fluctuations in plasma PGRN (n = 41) an...
Autores principales: | Meeter, Lieke H.H., Patzke, Holger, Loewen, Gordon, Dopper, Elise G.P., Pijnenburg, Yolande A.L., van Minkelen, Rick, van Swieten, John C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040889/ https://www.ncbi.nlm.nih.gov/pubmed/27703466 http://dx.doi.org/10.1159/000447738 |
Ejemplares similares
-
Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics
por: Teunissen, Charlotte E., et al.
Publicado: (2016) -
Symmetrical Corticobasal Syndrome Caused by a Novel c.314dup Progranulin Mutation
por: Dopper, Elise G. P., et al.
Publicado: (2011) -
Differential regulation of progranulin derived granulin peptides
por: Zhang, Tingting, et al.
Publicado: (2022) -
Potential effects of progranulin and granulins against retinal photoreceptor cell degeneration
por: Tanaka, Miruto, et al.
Publicado: (2019) -
Involvement of Progranulin and Granulin Expression in Inflammatory Responses after Cerebral Ischemia
por: Horinokita, Ichiro, et al.
Publicado: (2019)